WallStreetZenWallStreetZen

NASDAQ: GNFT
Genfit Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GNFT

Based on 1 analyst offering 12 month price targets for Genfit Sa

Min Forecast
$9.00+105.43%
Avg Forecast
$9.00+105.43%
Max Forecast
$9.00+105.43%

Should I buy or sell GNFT stock?

Based on 1 analyst offering ratings for Genfit Sa.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GNFT stock forecasts and price targets.

GNFT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-19

1 of 1

Forecast return on equity

Is GNFT forecast to generate an efficient return?

Company
-57.2%
Industry
123.99%
Market
-49.26%
GNFT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GNFT forecast to generate an efficient return on assets?

Company
-26.15%
Industry
47.19%
GNFT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GNFT earnings per share forecast

What is GNFT's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$0.01-67.74%
Avg 2 year Forecast
-$0.90-3,003.23%
Avg 3 year Forecast
-$0.24-874.19%

GNFT revenue forecast

What is GNFT's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$82.4M+11.45%
Avg 2 year Forecast
$68.3M-7.59%
Avg 3 year Forecast
$81.2M+9.89%
GNFT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GNFT revenue growth forecast

How is GNFT forecast to perform vs Biotechnology companies and vs the US market?

Company
0.24%
Industry
78.34%
Market
10.8%
GNFT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GNFT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GNFT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GNFT$4.38$9.00+105.43%Buy
ENGN$4.32$25.67+494.14%Strong Buy
ACIU$2.15$12.00+458.14%Buy
HRTX$1.40$4.50+221.43%Buy
AARD$9.77$32.80+235.72%Strong Buy
View Top Biotech Stocks

Genfit Sa Stock Forecast FAQ

Is Genfit Sa Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GNFT) stock is to Buy GNFT stock.

Out of 1 analyst, 0 (0%) are recommending GNFT as a Strong Buy, 1 (100%) are recommending GNFT as a Buy, 0 (0%) are recommending GNFT as a Hold, 0 (0%) are recommending GNFT as a Sell, and 0 (0%) are recommending GNFT as a Strong Sell.

If you're new to stock investing, here's how to buy Genfit Sa stock.

What is GNFT's earnings growth forecast for 2025-2027?

(NASDAQ: GNFT) Genfit Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.

Genfit Sa's earnings in 2025 is $1,712,500.On average, 1 Wall Street analyst forecast GNFT's earnings for 2025 to be $499,962, with the lowest GNFT earnings forecast at $499,962, and the highest GNFT earnings forecast at $499,962. On average, 1 Wall Street analyst forecast GNFT's earnings for 2026 to be -$44,996,567, with the lowest GNFT earnings forecast at -$44,996,567, and the highest GNFT earnings forecast at -$44,996,567.

In 2027, GNFT is forecast to generate -$11,999,084 in earnings, with the lowest earnings forecast at -$11,999,084 and the highest earnings forecast at -$11,999,084.

What is GNFT's revenue growth forecast for 2025-2027?

(NASDAQ: GNFT) Genfit Sa's forecast annual revenue growth rate of 0.24% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 78.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.

Genfit Sa's revenue in 2025 is $80,612,500.On average, 2 Wall Street analysts forecast GNFT's revenue for 2025 to be $4,117,435,816, with the lowest GNFT revenue forecast at $3,466,735,468, and the highest GNFT revenue forecast at $4,768,136,163. On average, 2 Wall Street analysts forecast GNFT's revenue for 2026 to be $3,413,989,493, with the lowest GNFT revenue forecast at $2,914,777,586, and the highest GNFT revenue forecast at $3,913,201,400.

In 2027, GNFT is forecast to generate $4,059,690,222 in revenue, with the lowest revenue forecast at $3,601,725,167 and the highest revenue forecast at $4,517,655,277.

What is GNFT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: GNFT) forecast ROA is -26.15%, which is lower than the forecast US Biotechnology industry average of 47.19%.

What is GNFT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GNFT price target, the average GNFT price target is $9.00, with the highest GNFT stock price forecast at $9.00 and the lowest GNFT stock price forecast at $9.00.

The Wall Street analyst predicted that Genfit Sa's share price could reach $9.00 by Aug 19, 2026. The average Genfit Sa stock price prediction forecasts a potential upside of 105.43% from the current GNFT share price of $4.38.

What is GNFT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GNFT) Genfit Sa's current Earnings Per Share (EPS) is $0.03. On average, analysts forecast that GNFT's EPS will be $0.01 for 2025, with the lowest EPS forecast at $0.01, and the highest EPS forecast at $0.01. On average, analysts forecast that GNFT's EPS will be -$0.90 for 2026, with the lowest EPS forecast at -$0.90, and the highest EPS forecast at -$0.90. In 2027, GNFT's EPS is forecast to hit -$0.24 (min: -$0.24, max: -$0.24).

What is GNFT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: GNFT) forecast ROE is -57.2%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.